Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Wall Street
Price Targets
Price Targets Summary
Zhejiang Hisun Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.
Operating Income
Forecast
Operating Income Estimate
Zhejiang Hisun Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 7%.
Net Income
Forecast
Net Income Estimate
Zhejiang Hisun Pharmaceutical Co Ltd
For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 1%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Zhejiang Hisun Pharmaceutical Co Ltd's stock price target?
Price Target
7.55
CNY
According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
5%
For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's revenue is 2%. The projected CAGR for the next 3 years is 5%.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's operating income is 4%. The projected CAGR for the next 3 years is 7%.
What is Zhejiang Hisun Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
1%
For the last 8 years the compound annual growth rate for Zhejiang Hisun Pharmaceutical Co Ltd's net income is 6%. The projected CAGR for the next 3 years is 1%.